Latest Health News
India Contains Nipah Virus Outbreak in West Bengal
Indian authorities confirmed two Nipah cases since December, quarantined 196 contacts all testing negative, and declared the situation under control. Asian nations like Indonesia, Thailand, Myanmar, Vietnam, and China ramped up airport screenings, travel advisories, and border monitoring as precaution.
Nipah, with 40-75% fatality rate per WHO, spreads via bats, pigs, and humans; no vaccine exists.
FDA Accepts NDA for 177Lu-edotreotide in GEP-NETs
FDA accepted ITM Radiopharma's New Drug Application for 177Lu-edotreotide based on Phase 3 COMPETE trial showing superior progression-free survival over everolimus with fewer adverse events. Decision expected by August 28, 2026, for somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
This radiotherapeutic marks potential advancement in targeted neuroendocrine cancer treatment.
FDA Grants Breakthrough Therapy for Bezuclastinib + Sunitinib in GIST
FDA awarded Breakthrough Therapy Designation to bezuclastinib combined with sunitinib for imatinib-refractory gastrointestinal stromal tumors based on PEAK trial results. Cogent plans NDA submission in April 2026 under Real-Time Oncology Review and Phase 2 trial mid-2026 for first-line exon 9 mutation patients.
Full PEAK results to be presented at major medical meeting in H1 2026.
Study Reveals High Underdiagnosis of Lassa Fever in West Africa
11% of febrile hospital admissions had Lassa fever despite no clinical suspicion; mortality tied to high viral loads and weak immune responses. Children aged 5-17 comprised 43% of cases; diagnostic gaps from limited PCR access and symptom overlap increase risks.
Urgent need for better detection, as over 30 imported cases to non-endemic countries had 33% fatality.
Scientists Warn Influenza D and Canine Coronavirus as Emerging Threats
Influenza D virus and canine coronavirus, of animal origin, pose public health risks due to lagging surveillance and diagnostics. Limited data indicate potential for human outbreaks if monitoring fails.
Published in Emerging Infectious Diseases journal.
First Participant Dosed in CRN09682 Trial for SST2-Positive Tumors
Phase 1/2 trial of CRN09682, first-in-human study for somatostatin receptor 2-positive tumors, dosed its first participant with plans for up to 150 enrollees. Includes dose-escalation for safety and Phase 2 for efficacy in selected cancers.
Part of advancing neuroendocrine cancer therapies.
New 3D Skin Model Identifies Herpes Simplex Treatments
NCATS developed a 3D skin tissue model using bioprinting to test potential new treatments for herpes simplex virus. Enables better identification of therapies mimicking human skin infection.
Announced January 27, 2026.
World NTD Day Highlights One Billion Affected by Neglected Tropical Diseases
NTDs impact over a billion people globally, especially children, perpetuating poverty cycles. Research partnerships and innovation via Global Health EDCTP3 and FESTMIH advance solutions ahead of January 30 World NTD Day.
Emphasizes need for advocacy and funding.
Vagus Nerve Implant Offers Long-Term Relief for Treatment-Resistant Depression
Vagus nerve stimulation implant improved symptoms for years in patients with long-standing, treatment-resistant depression. Many participants sustained benefits for at least two years after trying other options.
Reported January 20, 2026.
Sugar Metabolism Discovery Aids Neurodegenerative Disease Survival
Researchers found sugar metabolism acts as a survival switch in injured brain cells, preventing neuron collapse. Could open new treatments for Alzheimer's and other neurodegenerative diseases.
Published January 27, 2026.
New Research on Combination Therapies for Glioblastoma
UVA Health explores innovative drug combinations enhancing immune activation against glioblastoma and brain tumors. Aims to improve outcomes through targeted strategies.
Recent research spotlight.